Optimizing future treatment of enterococcal infections: Attacking the biofilm?

Trends in Microbiology

Volumn 20, Issue 1, 2012, Pages 40-49

  Paganelli, Fernanda L ^a   Willems, Rob J ^a   Leavis, Helen L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AGGREGATION SUBSTANCE PROTEIN; ANTIBIOTIC AGENT; AUTOLYSIN; BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; EF3314 PROTEIN; ENTEROCOCCAL POLYSACCHARIDE ANTIGEN; ENTEROCOCCAL SURFACE PROTEIN; GELATINASE; GLYCOSYLTRANSFERASE; GRAMICIDIN A; ISEGANAN; LINEZOLID; LIPOTEICHOIC ACID; LPXTG PROTEIN; MALTOSE; MICROBIAL SURFACE COMPONENT RECOGNIZING ADHESIVE MATRIX MOLECULE PROTEIN; ORITAVANCIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEGRIN; SALA PROTEIN; SALB PROTEIN; SERINE GLUTAMATE REPEAT CONTAINING PROTEIN A; SERINE PROTEINASE; SGRA PROTEIN; SIAMYCIN I; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHINE DEHYDROGENASE; ZINC METALLOPROTEASE GELATINASE;

ACM GENE; ANTIMICROBIAL ACTIVITY; AUTOLYSIS; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM PILUS; BEE GENE; BIOFILM; BIOFILM FORMATION; CATHETER INFECTION; CELL CONTACT; EBP GENE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EPAB GENE; FSR REGULON; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE LOCUS; GENE SILENCING; GLUCOSE METABOLISM; HUMAN; NONHUMAN; PERA GENE; PILA GENE; PILB GENE; PRIORITY JOURNAL; PROMOTER REGION; QUORUM SENSING; REGULON; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; URINARY TRACT INFECTION; XANTHINE DEHYDROGENASE GENE;

ANTI-BACTERIAL AGENTS; BIOFILMS; CROSS INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENE EXPRESSION REGULATION, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; VIRULENCE FACTORS;

ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

EID: 84855473165     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2011.11.001     Document Type: Review

References (81)

1. Hidron A.I., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 2008, 29:996-1011.
2. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15:167-193.
3. Sandoe J.A., et al. Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo. J. Med. Microbiol. 2003, 52:547-550.
4. O'Toole G., et al. Biofilm formation as microbial development. Annu. Rev. Microbiol. 2000, 54:49-79.
5. Witte W. Glycopeptide resistant Staphylococcus. J. Vet. Med. B: Infect. Dis. Vet. Public Health 2004, 51:370-373.
6. Willems R.J., et al. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 2001, 357:853-855.
7. Leavis H.L., et al. Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerg. Infect. Dis. 2003, 9:1108-1115.
8. Coque T.M., et al. High occurrence of esp among ampicillin-resistant and vancomycin-susceptible Enterococcus faecium clones from hospitalized patients. J. Antimicrob. Chemother. 2002, 50:1035-1038.
9. Shankar N., et al. Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect. Immun. 2001, 69:4366-4372.
10. Heikens E., et al. Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J. Bacteriol. 2007, 189:8233-8240.
11. Tendolkar P.M., et al. The N-terminal domain of enterococcal surface protein, Esp, is sufficient for Esp-mediated biofilm enhancement in Enterococcus faecalis. J. Bacteriol. 2005, 187:6213-6222.
12. Van Wamel W.J., et al. Growth condition-dependent Esp expression by Enterococcus faecium affects initial adherence and biofilm formation. Infect. Immun. 2007, 75:924-931.
13. Leendertse M., et al. Enterococcal surface protein transiently aggravates Enterococcus faecium-induced urinary tract infection in mice. J. Infect. Dis. 2009, 200:1162-1165.
14. Heikens E., et al. Contribution of the enterococcal surface protein Esp to pathogenesis of Enterococcus faecium endocarditis. Microbes Infect. 2011, 13:1185-1190.
15. Coburn P.S., et al. An AraC-type transcriptional regulator encoded on the Enterococcus faecalis pathogenicity island contributes to pathogenesis and intracellular macrophage survival. Infect. Immun. 2008, 76:5668-5676.
16. Kristich C.J., et al. Esp-independent biofilm formation by Enterococcus faecalis. J. Bacteriol. 2004, 186:154-163.
17. Chuang-Smith O.N., et al. Acceleration of Enterococcus faecalis biofilm formation by aggregation substance expression in an ex vivo model of cardiac valve colonization. PLoS ONE 2010, 5:e15798.
18. Chuang O.N., et al. Multiple functional domains of Enterococcus faecalis aggregation substance Asc10 contribute to endocarditis virulence. Infect. Immun. 2009, 77:539-548.
19. Johnson J.R., et al. Enterococcal aggregation substance and binding substance are not major contributors to urinary tract colonization by Enterococcus faecalis in a mouse model of ascending unobstructed urinary tract infection. Infect. Immun. 2004, 72:2445-2448.
20. Telford J.L., et al. Pili in Gram-positive pathogens. Nat. Rev. Microbiol. 2006, 4:509-519.
21. Nallapareddy S.R., et al. Endocarditis and biofilm-associated pili of Enterococcus faecalis. J. Clin. Invest. 2006, 116:2799-2807.
22. Nallapareddy S.R., et al. Conservation of Ebp-type pilus genes among enterococci and demonstration of their role in adherence of Enterococcus faecalis to human platelets. Infect. Immun. 2011, 79:2911-2920.
23. Singh K.V., et al. Importance of the ebp (endocarditis- and biofilm-associated pilus) locus in the pathogenesis of Enterococcus faecalis ascending urinary tract infection. J. Infect. Dis. 2007, 195:1671-1677.
24. Bourgogne A., et al. EbpR is important for biofilm formation by activating expression of the endocarditis and biofilm-associated pilus operon (ebpABC) of Enterococcus faecalis OG1RF. J. Bacteriol. 2007, 189:6490-6493.
25. Gao P., et al. Enterococcus faecalis rnjB is required for pilin gene expression and biofilm formation. J. Bacteriol. 2010, 192:5489-5498.
26. Tendolkar P.M., et al. Putative surface proteins encoded within a novel transferable locus confer a high-biofilm phenotype to Enterococcus faecalis. J. Bacteriol. 2006, 188:2063-2072.
27. Hendrickx A.P., et al. Differential PilA pilus assembly by a hospital-acquired and a community-derived Enterococcus faecium isolate. Microbiology 2010, 156:2649-2659.
28. Cobo Molinos A., et al. Detection of ebp (endocarditis- and biofilm-associated pilus) genes in enterococcal isolates from clinical and non-clinical origin. Int. J. Food Microbiol. 2008, 126:123-126.
29. Hendrickx A.P., et al. Expression of two distinct types of pili by a hospital-acquired Enterococcus faecium isolate. Microbiology 2008, 154:3212-3223.
30. Kim D.S., et al. The fms21 (pilA)-fms20 locus encoding one of four distinct pili of Enterococcus faecium is harboured on a large transferable plasmid associated with gut colonization and virulence. J. Med. Microbiol. 2010, 59:505-507.
31. Sillanpaa J., et al. Characterization of the ebp(fm) pilus-encoding operon of Enterococcus faecium and its role in biofilm formation and virulence in a murine model of urinary tract infection. Virulence 2010, 1:236-246.
32. Sillanpaa J., et al. Identification and phenotypic characterization of a second collagen adhesin, Scm, and genome-based identification and analysis of 13 other predicted MSCRAMMs, including four distinct pilus loci, in Enterococcus faecium. Microbiology 2008, 154:3199-3211.
33. Heilmann C. Adhesion mechanisms of staphylococci. Adv. Exp. Med. Biol. 2011, 715:105-123.
34. Nallapareddy S.R., et al. A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen. Infect. Immun. 2008, 76:4110-4119.
35. Nallapareddy S.R., et al. Contribution of the collagen adhesin Acm to pathogenesis of Enterococcus faecium in experimental endocarditis. Infect. Immun. 2008, 76:4120-4128.
36. Hendrickx A.P., et al. SgrA, a nidogen-binding LPXTG surface adhesin implicated in biofilm formation, and EcbA, a collagen binding MSCRAMM, are two novel adhesins of hospital-acquired Enterococcus faecium. Infect. Immun. 2009, 77:5097-5106.
37. Creti R., et al. Surface protein EF3314 contributes to virulence properties of Enterococcus faecalis. Int. J. Artif. Organs 2009, 32:611-620.
38. Teng F., et al. Further characterization of the epa gene cluster and Epa polysaccharides of Enterococcus faecalis. Infect. Immun. 2009, 77:3759-3767.
39. Guiton P.S., et al. Contribution of autolysin and sortase A during Enterococcus faecalis DNA-dependent biofilm development. Infect. Immun. 2009, 77:3626-3638.
40. Hancock L.E., Perego M. The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase. J. Bacteriol. 2004, 186:5629-5639.
41. Arciola C.R., et al. Strong biofilm production, antibiotic multi-resistance and high gelE expression in epidemic clones of Enterococcus faecalis from orthopaedic implant infections. Biomaterials 2008, 29:580-586.
42. Qin X., et al. Characterization of fsr, a regulator controlling expression of gelatinase and serine protease in Enterococcus faecalis OG1RF. J. Bacteriol. 2001, 183:3372-3382.
43. Thomas V.C., et al. Regulation of autolysis-dependent extracellular DNA release by Enterococcus faecalis extracellular proteases influences biofilm development. J. Bacteriol. 2008, 190:5690-5698.
44. Thomas V.C., et al. A fratricidal mechanism is responsible for eDNA release and contributes to biofilm development of Enterococcus faecalis. Mol. Microbiol. 2009, 72:1022-1036.
45. Singh K.V., et al. Fsr-independent production of protease(s) may explain the lack of attenuation of an Enterococcus faecalis fsr mutant versus a gelE-sprE mutant in induction of endocarditis. Infect. Immun. 2005, 73:4888-4894.
46. Mylonakis E., et al. The Enterococcus faecalis fsrB gene, a key component of the fsr quorum sensing system, is associated with virulence in the rabbit endophthalmitis model. Infect. Immun. 2002, 70:4678-4681.
47. Sifri C.D., et al. Virulence effect of Enterococcus faecalis protease genes and the quorum sensing locus fsr in Caenorhabditis elegans and mice. Infect. Immun. 2002, 70:5647-5650.
48. Thurlow L.R., et al. Gelatinase contributes to the pathogenesis of endocarditis caused by Enterococcus faecalis. Infect. Immun. 2010, 78:4936-4943.
49. Fabretti F., et al. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect. Immun. 2006, 74:4164-4171.
50. Theilacker C., et al. Glycolipids are involved in biofilm accumulation and prolonged bacteraemia in Enterococcus faecalis. Mol. Microbiol. 2009, 71:1055-1069.
51. Mohamed J.A., et al. Pleiotrophic effects of 2 Enterococcus faecalis sagA-like genes, salA and salB, which encode proteins that are antigenic during human infection, on biofilm formation and binding to collagen type I and fibronectin. J. Infect. Dis. 2006, 193:231-240.
52. Bourgogne A., et al. Comparison of OG1RF and an isogenic fsrB deletion mutant by transcriptional analysis: the Fsr system of Enterococcus faecalis is more than the activator of gelatinase and serine protease. J. Bacteriol. 2006, 188:2875-2884.
53. Pillai S.K., et al. Effects of glucose on fsr-mediated biofilm formation in Enterococcus faecalis. J. Infect. Dis. 2004, 190:967-970.
54. Baldassarri L., et al. Enterococcus spp. produces slime and survives in rat peritoneal macrophages. Med. Microbiol. Immunol. 2001, 190:113-120.
55. Creti R., et al. Enterococcal colonization of the gastro-intestinal tract: role of biofilm and environmental oligosaccharides. BMC Microbiol. 2006, 6:60.
56. Kristich C.J., et al. Development and use of an efficient system for random mariner transposon mutagenesis to identify novel genetic determinants of biofilm formation in the core Enterococcus faecalis genome. Appl. Environ. Microbiol. 2008, 74:3377-3386.
57. Ballering K.S., et al. Functional genomics of Enterococcus faecalis: multiple novel genetic determinants for biofilm formation in the core genome. J. Bacteriol. 2009, 191:2806-2814.
58. Srivastava M., et al. A selenium-dependent xanthine dehydrogenase triggers biofilm proliferation in Enterococcus faecalis through oxidant production. J. Bacteriol. 2011, 193:1643-1652.
59. El Karim I., et al. The antimicrobial effects of root canal irrigation and medication. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2007, 103:560-569.
60. Darouiche R.O. Antimicrobial coating of devices for prevention of infection: principles and protection. Int. J. Artif. Organs 2007, 30:820-827.
61. Boswald M., et al. Antimicrobial activity and biocompatibility of polyurethane and silicone catheters containing low concentrations of silver: a new perspective in prevention of polymer-associated foreign-body-infections. Zentralbl Bakteriol 1995, 283:187-200.
62. Peterson W.J., et al. Treatment of dialysis catheter-related Enterococcus bacteremia with an antibiotic lock: a quality improvement report. Am. J. Kidney Dis. 2009, 53:107-111.
63. Maki D.G., et al. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit. Care Med. 2011, 39:613-620.
64. Yala J.F., et al. Elaboration of antibiofilm materials by chemical grafting of an antimicrobial peptide. Appl. Microbiol. Biotechnol. 2010, 89:623-634.
65. Ghiselli R., et al. Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. J Parenter. Enteral Nutr. 2007, 31:463-468.
66. Nakayama J., et al. Siamycin attenuates fsr quorum sensing mediated by a gelatinase biosynthesis-activating pheromone in Enterococcus faecalis. J. Bacteriol. 2007, 189:1358-1365.
67. Balaban N., et al. Treatment of Staphylococcus aureus biofilm infection by the quorum sensing inhibitor RIP. Antimicrob. Agents Chemother. 2007, 51:2226-2229.
68. Belley A., et al. Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro. Antimicrob. Agents Chemother. 2009, 53:918-925.
69. Manetti A.G., et al. Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol. Microbiol. 2007, 64:968-983.
70. Quigley B.R., et al. A foreign protein incorporated on the tip of T3 pili in Lactococcus lactis elicits systemic and mucosal immunity. Infect. Immun. 2010, 78:1294-1303.
71. Escaich, S. et al. Mutabilis SA. New imidazolo-heteroaryl derivatives with antibacterial properties, EP2155750.
72. Kim S.W., et al. Inhibition of the bacterial surface protein anchoring transpeptidase sortase by medicinal plants. Biosci. Biotechnol. Biochem. 2002, 66:2751-2754.
73. Maresso A.W., Schneewind O. Sortase as a target of anti-infective therapy. Pharmacol. Rev. 2008, 60:128-141.
74. Ramasubbu N., et al. Structural analysis of dispersin B, a biofilm-releasing glycoside hydrolase from the periodontopathogen Actinobacillus actinomycetemcomitans. J. Mol. Biol. 2005, 349:475-486.
75. Schommer N.N., et al. Staphylococcus epidermidis uses distinct mechanisms of biofilm formation to interfere with phagocytosis and activation of mouse macrophage-like cells 774A.1. Infect. Immun. 2011, 79:2267-2276.
76. Boles B.R., Horswill A.R. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 2008, 4:e1000052.
77. Guo Q.Y., et al. Treatment of Streptococcus mutans with antisense oligodeoxyribonucleotides to gtfB mRNA inhibits GtfB expression and function. FEMS Microbiol. Lett. 2006, 264:8-14.
78. Li L.N., et al. Targeted antimicrobial therapy against Streptococcus mutans establishes protective non-cariogenic oral biofilms and reduces subsequent infection. Int. J. Oral Sci. 2010, 2:66-73.
79. Clancy K.W., et al. Sortase transpeptidases: insights into mechanism, substrate specificity, and inhibition. Biopolymers 2010, 94:385-396.
80. Otto M. Novel targeted immunotherapy approaches for staphylococcal infection. Expert Opin. Biol. Ther. 2010, 10:1049-1059.
81. Romero D., Kolter R. Will biofilm disassembly agents make it to market?. Trends Microbiol. 2011, 19:304-306.